$AMARQ Amarillo Biosciences is working with global
Post# of 61
Posted On: 02/10/2014 8:57:53 AM
$AMARQ Amarillo Biosciences is working with global partners to conduct clinical studies to establish the safety and efficacy of low-dose interferon-alpha given in the form of orally dissolving lozenges to treat a number of significant human diseases, including influenza and hepatitis C
(0)
(0)AINOS Inc. (AIMDD) Stock Research Links
Scroll down for more posts ▼